The National Institute on Aging (NIA) awarded a $558,193 Cooperative Agreement under the Aging Research Federal Grant Program (CFDA 93.866) to The Regents of the University of California, San Francisco (UCSF) for the "Bridging Research Infrastructure for Dementia Gaps in East Africa (BRIDGE-AFRICA)" project. The funding will be used to build research infrastructure for Alzheimer's disease and related dementias (ADRD) in East Africa, building on UCSF's existing expertise and...
This Cooperative Agreement award from the National Institute on Aging (part of the U.S. Department of Health and Human Services), under the Aging Research Federal Grant Program (CFDA 93.866), will provide $539,352 to incorporate portable, low-field brain MRI into a population-representative study of Alzheimer's disease and related dementias in rural South Africa. The project, led by The Trustees of Columbia University in the City of New York, aims to transform the ability to assess brain atrophy...
This Cooperative Agreement was awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to build research infrastructure for studying Alzheimer's disease and related dementias (AD/ADRD) in Côte d'Ivoire. The total funding amount is $517,593, with an award date of April 15, 2025 and an ultimate completion date of March 31, 2027. The project is a collaboration between Johns Hopkins Bloomberg School of Public Health (JHBSPH) in the U.S. and Ecole Nationale de Statistiques et...
The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $487,386 cooperative agreement award from the National Institute on Aging (CFDA 93.866 Aging Research) to build research infrastructure and capacity for large-scale dementia research in French-speaking Africa (the BUILD-FSA project). The 2-year project, starting February 1, 2025, will leverage prior partnerships between UTHSCSA's South Texas Alzheimer's Disease Research Center and the Brain Research Africa...
This Cooperative Agreement award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $536,527 to the University of Miami to establish the Global Alzheimer's and Dementia Partnership to Advance Neuroscience in LMICs (GAP-ADN) Coordinating Center. The key objectives are to coordinate consortium activities, promote collaboration across the Alzheimer's and dementia research community, facilitate training opportunities, and coordinate data sharing to integrate research progress...
The National Institute on Aging (NIA) awarded a $215,509 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to the Botswana-University of Maryland School of Medicine Health Initiatives (BUMMHI) to develop infrastructure for aging and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) research in Botswana. The RAISE-BOTSWANA project aims to support the career development of a local research scientist, Dr. Lillian Okui, through professional...
This federal Project Grant award of $223,813 from the National Institute on Aging (CFDA 93.866 Aging Research) supports a 2-year cross-sectional and longitudinal study in Nigeria to investigate the use of plasma biomarkers, social determinants of health, and lifestyle factors in classifying and predicting mild cognitive impairment and Alzheimer's disease. The study will enroll 264 participants across three cognitive status groups (Alzheimer's disease, mild cognitive impairment, and healthy...
This $2,365,042 Project Grant was awarded by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866) to conduct research on the biological underpinnings of Alzheimer's disease and related dementias (ADRD). The research aims to better characterize the interplay between biological markers of neurodegeneration, vascular, nutritional, and inflammatory systems, and their interface with social and economic factors, by leveraging cross-national comparisons...
This $2,528,708 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research on the impact of undiagnosed Alzheimer's disease and related dementias (AD/ADRD) on healthcare utilization across geographic regions in the United States. The project will leverage Medicare claims data and cognitive assessment data from the REGARDS longitudinal cohort study to model the timeframe and consequences of undiagnosed AD/ADRD at the county and hospital...
The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $344,164 project grant to Northwestern University to develop "M4: Modules on Advanced Methodology When Modeling Multinational Data." The primary objectives are to: 1) create a training program in large-scale data analysis for the next generation of researchers, 2) instruct trainees on protective behavioral and social factors related to Alzheimer's disease and related dementias...
This federal Cooperative Agreement award for $455,035 was granted on August 15, 2025 by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The award, titled "Leading Equitable Research in Alzheimer's Disease in Africa (LEAD Africa)," aims to establish an Alzheimer's disease and related dementias (AD/ADRD) research infrastructure in resource-limited areas of Africa. The project will be executed through a collaboration between research teams from Ghana, Tanzania, Republic of the Congo, and the U.S.-based Boston University. Key objectives include developing and pilot testing culturally appropriate study protocols, establishing a data management and sharing platform, and forming an external advisory board to provide expert guidance. The 2-year exploratory/development phase will focus on fostering the research consortia, providing bi-directional training and mentorship, and laying the groundwork for the broader research program.